| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/04/2011 | WO2011041304A3 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase |
| 08/04/2011 | WO2011031073A3 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof |
| 08/04/2011 | US20110190520 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives |
| 08/04/2011 | US20110190497 Process for production of 2,5 dioxopyrrolidine 3 carboxylate |
| 08/04/2011 | US20110190496 FUSED BICYCLIC mTOR INHIBITORS |
| 08/04/2011 | US20110190495 N-butyramide, the preparation method and use thereof |
| 08/04/2011 | US20110190489 Novel Tricyclic Compounds |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190292 Heterobicyclic compounds useful as kinase inhibitors |
| 08/04/2011 | US20110190283 Fab I Inhibitors |
| 08/04/2011 | US20110190281 Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis |
| 08/04/2011 | US20110190275 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 08/04/2011 | US20110190269 Gamma secretase modulators |
| 08/04/2011 | US20110190266 5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) |
| 08/04/2011 | US20110190239 Bmi-1 protein expression modulators |
| 08/04/2011 | US20110189740 Catalyst for the decomposition of lignin, method for the preparation of alcohols and organic acids, method for the preparation of lignin-decomposition products, catalyst for the decomposition of aromatic hydrocarbons, method for releasing hydrogen ions, as well as porphyrin |
| 08/04/2011 | US20110189129 Hepatitis c virus inhibitors |
| 08/04/2011 | US20110186821 Azapyrenes for electronic applications |
| 08/04/2011 | DE102009043862A1 Acylierte Phthalocyanine Acylated phthalocyanines |
| 08/04/2011 | CA2788364A1 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof |
| 08/04/2011 | CA2787407A1 5-alkynyl-pyrimidines |
| 08/04/2011 | CA2787396A1 5-alkynyl pyrimidines and their use as kinase inhibitors |
| 08/04/2011 | CA2787363A1 Pyrazolopyrimidine kinase inhibitors |
| 08/04/2011 | CA2780421A1 Gamma secretase modulaters |
| 08/03/2011 | EP2351756A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 08/03/2011 | EP2351755A1 New crystalline forms of pemetrexed diacid, and preparations thereof |
| 08/03/2011 | EP2351751A1 Substituted pyrazolopyrimidines |
| 08/03/2011 | EP2350097A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/03/2011 | EP2350087A1 Regioselective reduction of fused pyrrolocarbazoles-5,7-diones |
| 08/03/2011 | EP2350086A2 Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| 08/03/2011 | EP2350085A1 Quinazolinone linked pyrroloý2,1 -c¨ý1.4¨benzodiazepine hybrids as potential anticancer agents and process forthe preparation thereof |
| 08/03/2011 | EP2350084A1 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor |
| 08/03/2011 | EP2350083A1 Pyrido [5, 4-d]pyrimidines as cell proliferation inhibitors |
| 08/03/2011 | EP2350082A1 Choline and tromethamine salt of licofelone |
| 08/03/2011 | EP2350081A1 Imidazopyridazinecarbonitriles useful as kinase inhibitors |
| 08/03/2011 | EP2350080A1 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases |
| 08/03/2011 | EP2350079A1 Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes |
| 08/03/2011 | EP2350078A2 Compounds that expand hematopoietic stem cells |
| 08/03/2011 | EP2350067A2 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 08/03/2011 | EP2350058A2 Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt |
| 08/03/2011 | EP2350053A2 Soluble mtor complexes and modulators thereof |
| 08/03/2011 | EP2350052A2 Antiproliferative compounds |
| 08/03/2011 | EP2350017A1 Amide compounds useful in therapy |
| 08/03/2011 | EP2350002A1 Novel compounds as calcium channel blockers |
| 08/03/2011 | EP2349279A1 Modulators of aldehyde dehydrogenase and methods of use thereof |
| 08/03/2011 | EP2349276A2 Hiv integrase inhibitors |
| 08/03/2011 | EP2348860A1 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 08/03/2011 | EP2348843A1 Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same |
| 08/03/2011 | EP1761537B1 Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof |
| 08/03/2011 | EP1474426B1 Process for making carbapenem compounds |
| 08/03/2011 | CN1964970B Iap的抑制剂 Iap inhibitors |
| 08/03/2011 | CN1898240B Imidazopyrazine tyrosine kinase inhibitors |
| 08/03/2011 | CN1720238B Neurologically-active compounds |
| 08/03/2011 | CN102143965A Pyrazolopyrimidines and their use for the treatment of CNS disorders |
| 08/03/2011 | CN102143959A Hepatitis c virus inhibitors |
| 08/03/2011 | CN102143952A Lead, wiring member, package part, metal part provided with resin and resin-sealed semiconductor device, and methods for producing same |
| 08/03/2011 | CN102143750A Macrocyclics pyrimidines as aurora kinase inhibitors |
| 08/03/2011 | CN102143746A CDK modulators |
| 08/03/2011 | CN102140100A Polycyclic compound for inhibiting hepatitis C virus efficiently, preparation method thereof and application thereof |
| 08/03/2011 | CN102140099A Novel pyridine derivative |
| 08/03/2011 | CN102140098A 7-(2-substituted-3-amino-1-pyrrolidine[3, 4-c]pyrazolyl) quinoline carboxylic acid derivatives, preparation method thereof and application thereof in antibiosis and anti-tuberculosis |
| 08/03/2011 | CN101497617B Method for producing hexamethylene tetramin by formaldehyde-containing wastewater |
| 08/03/2011 | CN101379066B HCV NS5B inhibitors |
| 08/03/2011 | CN101273043B Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
| 08/02/2011 | US7989621 Method for producing substituted imidazo[1,2-A]pyrazines of (s)-1-(3-(2-sec-butyl-6-(1h-indol-3-yl)-3-oxo-3,7-dihydroimadazo[1,2-a]pyrazin-8-yl)propyl)guanidine |
| 08/02/2011 | US7989596 Method of altering the binding specificity of monoclonal antibodies by oxidation-reduction reactions |
| 08/02/2011 | US7989464 mGluR1 antagonists as therapeutic agents |
| 08/02/2011 | US7989451 Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer treatments |
| 08/02/2011 | US7989444 Compounds having affinity for dopamine D3 receptor and uses thereof |
| 08/02/2011 | US7989089 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) |
| 08/02/2011 | US7988952 Condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns |
| 08/02/2011 | CA2608890C Heterobicyclic metalloprotease inhibitors |
| 08/02/2011 | CA2474043C Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 08/02/2011 | CA2395593C Azaindoles |
| 07/28/2011 | WO2011090333A2 Chlorine derivative/unsaturated fatty acid conjugates, photosensitizers comprising same, and cancer treatment compositions to be used in photodynamic therapy comprising same |
| 07/28/2011 | WO2011090317A2 Imidazopyrazinone derivatives with apoptosis inducing activity on cells |
| 07/28/2011 | WO2011089509A1 A process for the preparation of novel porphyrin derivatives and their use as pdt agents and fluorescence probes |
| 07/28/2011 | WO2011089400A1 Inhibitors of pi3 kinase |
| 07/28/2011 | WO2011088836A1 NOVEL 4-(ARYL-4-SULFONYL)-6,6a,7,8,9,10-HEXAHYDRO-4H-4,8,10a-TRIAZA-ACEPHENANTHRYLENE AND 3-ARYLSULFONYL-6,6a,7,8,9,10-HEXAHYDRO-3H-3,8,10a-TRIAZA-CYCLOPENTA[C]FLUORENE DERIVATIVES AS SEROTONIN 5-HT6 LIGANDS |
| 07/28/2011 | US20110184166 Geometric synthesis of porphyrin rods |
| 07/28/2011 | US20110184001 Inhibitors of bruton's tyrosine kinase |
| 07/28/2011 | US20110184000 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivates and their use as pde9a modulators |
| 07/28/2011 | US20110183992 Therapeutic agent for migraine |
| 07/28/2011 | US20110183989 Saturated bicyclic heterocyclic derivatives as smo antagonists |
| 07/28/2011 | US20110183983 Heterocyclic compound as protein kinase inhibitor |
| 07/28/2011 | US20110183972 Aromatic ring fused triazine derivatives and uses thereof |
| 07/28/2011 | US20110183971 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/28/2011 | US20110183966 Aminopyridine kinase inhibitors |
| 07/28/2011 | US20110183939 Novel pyrolinone derivative and pharmaceutical composition comprising the same |
| 07/28/2011 | US20110182854 Hcv protease inhibitors |
| 07/28/2011 | US20110182812 Imaging Agents for Detecting Neurological Disorders |
| 07/28/2011 | CA2787714A1 Inhibitors of pi3 kinase |
| 07/27/2011 | EP2348023A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/27/2011 | EP2346875A1 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy |
| 07/27/2011 | EP2346874A1 Process for preparing chlorins and their pharmaceutical uses |
| 07/27/2011 | EP2346873A1 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists |
| 07/27/2011 | EP2346872A1 Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
| 07/27/2011 | EP2346871A1 Alpha helix mimetics in the treatment of cancer |
| 07/27/2011 | EP2346859A1 Heterocyclic jak kinase inhibitors |
| 07/27/2011 | EP2346508A1 Heterocyclic kinase inhibitors |